JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyomura, T.
Right arrow Articles by Futai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyomura, T.
Right arrow Articles by Futai, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 12, 8760-8765, March 24, 2000


Three Subunit a Isoforms of Mouse Vacuolar H+-ATPase
PREFERENTIAL EXPRESSION OF THE a3 ISOFORM DURING OSTEOCLAST DIFFERENTIATION*

Takao Toyomura, Toshihiko Oka, Chie Yamaguchi, Yoh Wada, and Masamitsu FutaiDagger

From the Division of Biological Sciences, Institute of Scientific and Industrial Research, Osaka University, Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation, Osaka 567-0047, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Vacuolar H+-ATPase (V-ATPase) is a multi-subunit enzyme with a membrane peripheral catalytic (V1) and an intrinsic (Vo) sector. We have identified three cDNA clones coding for isoforms of mouse Vo subunit a (a1, a2, and a3). They exhibit 48-52% identity with each other and high similarity to subunit a of other species. The a1 isoform was mainly expressed in brain and liver. The a2 isoform was observed in heart and kidney in addition to brain and liver. Transcripts for the a3 isoform were strongly expressed in heart and liver. The a3 isoform was induced during osteoclast differentiation, and localized in the plasma membrane and cytoplasmic filamentous structures. In contrast to a3, the a1 isoform was constitutively expressed and localized in the cytoplasmic endomembrane compartments of the same cells. These findings suggest that the a3 isoform is a component of the plasma membrane V-ATPase essential for bone resorption.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The acidification of intracellular compartments is driven by a vacuolar-type H+-ATPase (V-ATPase)1 and is essential for processes such as zymogen activation, protein sorting, receptor-mediated endocytosis, and neurotransmitter uptake into synaptic vesicles (1-4). V-ATPases are also localized in the plasma membranes of epithelial cells of tissues such as kidney, seminal duct, and bladder (5-7). V-ATPase localized in the ruffled border membranes of osteoclasts secretes protons to dissolve mineral components of bones for remodeling (8, 9). A ring of actin filaments bound to the ruffled membrane restricts the cell surface region attached to the bone (10, 11). Recent studies suggested that V-ATPase is associated with the cytoskeleton including actin filaments (12, 13).

V-ATPase is a complex of at least 13 different subunits forming two functional sectors, V1 and Vo (1). The V1 sector consisting of eight subunits (A-H) has three catalytic sites at the interface between the A and B subunits, similar to ATP synthase (F1Fo) (14), whereas the Vo sector (a, c, c', c", and d) forms a proton pathway. Although subunit a, also called the 116-kDa subunit, is a major component of the Vo sector, its function remains unknown. Yeast has two different forms of subunit a, Vph1p and Stv1p (15, 16). Proteolipid subunits (c, c', and c") are thought to be directly involved in proton translocation. Recent studies indicated that subunit c isoforms are present in several species (17-24). Isoforms of other subunits have also been found in vertebrates (25-34). Mutations of the gene for one of the two B subunits (B1) cause renal tubular acidosis with sensorineural deafness in humans (35). However, the roles of other subunit isoforms have not been clearly defined. The divergence of the subunits may be responsible for the regulation of enzyme activity and/or its localization in specific tissues or subcellular compartments.

In this study, three cDNA clones coding for mouse subunit a were identified and their gene products were designated as a1, a2, and a3. They exhibit 48-52% sequence identity with each other and high similarity with the corresponding subunits of other vertebrates. One of them, the a3 subunit, was induced during osteoclast differentiation, and localized in the plasma membrane, whereas a1 was distributed in the dot-like structures, presumably endomembrane organelles, in osteoclasts. These results suggest that a3 is a key subunit of V-ATPase for its localization in the plasma membranes of osteoclasts, and thus for bone resorption.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- A SuperscriptTM mouse 13.5 day embryo cDNA library (SuperscriptTM), alpha -minimum essential medium (alpha -MEM), and fetal bovine serum were purchased from Life Technologies, Inc. Radioactive materials were from Amersham Pharmacia Biotech. Enzymes for molecular cloning were from Takara Shuzo Co., Ltd. 1alpha ,25-Dihydroxy cholecalciferol (1,25(OH)2 D3) was from Sigma. The ddY male mice were from Japan SLC Co., Ltd. Nitrocellulose membranes were from Advantec. The mouse expressed sequence tag (EST) clones were from Genome System Inc. and American Type Culture Collection.

Cloning of Subunit a Isoforms-- One mouse EST clone (AA444415) was prepared and sequenced using a model 377 DNA sequencer (Applied Biosystem). Since the cDNA lacked the 5' region, a mouse embryo cDNA library was screened to isolate a full-length clone. On screening (1 × 107 colonies), a single clone was isolated and sequenced. The clone contained a full-length cDNA, although two introns (79 and 308 bp) were present in the open reading frame. To remove these introns, a DNA fragment was amplified by reverse transcribed PCR using mRNA prepared from 13.5-day mouse embryos, and then cloned. The resulting product was introduced into the corresponding region of the cDNA clone to construct a complete cDNA coding for the a3 isoform.

Mouse EST clones (AA980626 and AA611922, coding for the a1 and a2 isoforms, respectively) were sequenced. The 5' region of each clone was obtained by 5'-RACE using mRNA from 13.5-day mouse embryos. The PCR products were sequenced and ligated with the corresponding cDNAs to create full-length clones for a1 and a2. The entire cDNAs for a1, a2, and a3 were 3815, 2917, and 2587 bp (not including polyadenylation), respectively.

Northern Blot-- Northern blot analysis was carried out using multiple tissue blots (CLONTECH) according to the manufacturer's recommendations. Each probe was prepared from a cDNA clone (a1, +851 to +1286 bp; a2, -2 to +956 bp; and a3, +479 to +1161 bp; numbering from the first letter of the initiation codon), and labeled with [alpha -32P]dCTP using Ready-To-GoTM DNA labeling beads (Amersham Pharmacia Biotech). Filter was hybridized with a probe using ExpressHyb hybridization solution (CLONTECH) at 68 °C for 60 min. The radioactive filters were analyzed with BAS-1000 (Fuji Film).

Genomic Southern Blot-- Genomic DNA (10 µg) from 129/Sv mice was digested with restriction enzymes, electrophoresed on an agarose gel, and then blotted onto a filter. Radioactive probes were prepared from cDNA clones (a1, +847 to +1310 bp; a2, -18 to +502 bp; and a3, +1721 to +2042 bp).

Preparation of Antibodies against Subunit a Isoforms-- Synthetic peptides (a1, RRCEEMDRKLRFVEKEI, positions 56-72; and a3, HRHRRNTQRRPAGQQDE, positions 660-676) were used to raise isoform-specific antibodies. The antibodies were purified using a recombinant protein-conjugated affinity columns, HiTrap® (Amersham Pharmacia Biotech). Anti-a2 antiserum was generated by immunizing rabbits with a recombinant protein including a part of a2 (615-742 residues), and affinity-purified using the same protein.

Culture of Mouse Bone Marrow Cells-- Osteoclasts were generated from a mouse bone marrow cell culture (36). After sacrifice by cervical dislocation, the tibiae of ddY male mice were aseptically removed and dissected free of adhering tissues. The bone ends were cut off, and the marrow cells were flushed out with alpha -MEM medium. These cells were cultured at 2 × 106 cells/ml in alpha -MEM containing 10% fetal bovine serum, and maintained by replacing the medium every 2 days with new one containing 1,25(OH)2 D3 (5 × 10-8 M) at 37 °C (5% CO2). Histochemical staining for tartrate-resistant acid phosphatase activity was performed to confirm the presence of osteoclasts (36, 37).

Western Blot-- Cells were solubilized in 50 mM Tris-HCl buffer (pH 6.8) containing 10% glycerol and 2% SDS, and then heated at 60 °C for 5 min. Samples were separated by polyacrylamide gel electrophoresis in the presence of the same detergent and then transferred electrophoretically to nitrocellulose membranes. Immunodetection was carried out using alkaline phosphatase-conjugated antibodies, 5-bromo-4-chloro-3-indolyl phosphate and 4-nitro blue tetrazolium chloride.

Immunofluorescence Microscopy-- Cells were fixed for 25 min with 2% paraformaldehyde in 0.2 M sodium phosphate buffer (pH 7.0) at room temperature, and then rinsed with the same buffer containing 0.1 M glycine. Following the fixation, the cells were soaked with a permeabilization solution (0.4% saponin, 1% bovine serum albumin, and 2% normal goat serum in phosphate-buffered saline) for 15 min at room temperature, and then incubated for 60 min with the antibodies against subunit a and washed with the same solution. They were incubated with fluorescein isothiocyanate-conjugated antibodies (Jackson Immunoresearch Laboratories Inc.) for 60 min, washed with the same solution, and then mounted with Vector Shield (Vector Laboratories). Fluorescence images were acquired using LSM 510 (Carl Zeiss).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of Three Mouse cDNA Clones for V-ATPase Subunit a Isoforms-- A search of mouse EST data bases using the amino acid sequence of bovine subunit a (30) led to the identification of three clones (AA980626, AA611922, and AA444415) that could code partial sequences of proteins similar to the subunit a of other species. Since one EST clone (AA444415) lacked the 5' region, we searched a mouse cDNA library and obtained one full-length clone corresponding to the EST. For the other two clones (AA980626 and AA611922), 5'-RACE was carried out using 13.5-day embryo mRNA, and full-length cDNAs were constructed from the PCR products and the corresponding clones. Based on the similarity with the subunit a of other species (see below), the proteins encoded by the cDNAs were named the a1, a2, and a3 subunits (Fig. 1).


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 1.   Alignment of the amino acid sequences of subunit a isoforms. The deduced amino acid sequences of subunit a isoforms (a1, a2, and a3) were aligned to obtain maximal homology. Open and shaded boxes represent identical residues in the three isoforms and putative N-linked glycosylation sites (N-X-S/T), respectively. Putative transmembrane domains (I-IX) were defined by hydropathy analysis, and are similar to the topology model of yeast subunit a (Vph1p) proposed by Leng et al. (39).

Amino Acid Sequences and Transmembrane Structures of Subunit a Isoforms-- The a1, a2, and a3 isoforms comprised 832, 856, and 834 amino acid residues, respectively. Hydropathy plot analysis (38) indicated that these isoforms had closely similar structures with nine putative transmembrane regions (Fig. 1, I-IX), as proposed by Leng et al. (39). Higher conservation was observed in the putative transmembrane regions. The a1 and a2 isoforms had single potential N-linked glycosylation sites at positions 489 and 505, respectively, whereas the a3 isoform contained three sites at positions 484, 504, and 595 (Fig. 1, shaded boxes). The a1, a2, and a3 isoforms exhibited 48-52% identity with each other. The a1 isoform showed 95 and 99% identity to the subunit a of bovine and rat clathrin-coated vesicles, respectively (30, 40). The a2 isoform was identical to a putative immunoregulatory protein from mouse T cells (25) except for a replacement (Ser right-arrow Cys) at position 486 and a Leu insertion at position 788 in the a2 isoform. This difference may be due to the mouse strains used for cloning. The a2 isoform exhibited 91% identity with the subunit a purified from bovine lung (34). The a3 isoform showed 84% identity with the polypeptide encoded by OC-116-kDa from a human osteoclastoma (31).

Tissue Distributions of Subunit a Isoforms-- Northern blot analysis revealed that a 4.2-kb a1 transcript was present in all tissues examined (Fig. 2). High levels of expression were observed in brain and liver, as previously reported (30, 40). Expression of the a2 transcript was detectable in heart, brain, liver, and kidney. The a3 transcript was observed predominantly in heart and liver. Low but significant expression of the a3 isoform was found in brain, spleen, lung, and kidney. Transcripts of different sizes, possibly due to alternative splicing, were detected for the a2 and a3 isoforms: a2, 2.6, 3.0, and 4.9 kb; a3, 2.5 and 3.2 kb. We identified an EST clone (AA591593) for the a2 isoform, containing an additional 599-bp 3' untranslational region, presumably corresponding to the splicing variant of the EST clone described above.


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 2.   Northern blot analysis of subunit a isoforms. Poly(A+) RNAs (2 µg) from heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis were subjected to electrophoresis, blotted onto a filter, and then hybridized with radioactive probes of the indicated isoforms. The blot was also hybridized with a control probe of human beta -actin. Arrowheads indicate the positions of the transcripts.

Southern blot analysis of mouse genomic DNA indicated that a single gene for the a3 isoform was present in the mouse genome (Fig. 3). The genomic DNAs for the a1 and a2 isoforms gave more than one band depending on the endonucleases used, suggesting that there may be related sequences in the genome.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 3.   Genomic Southern blot analysis of subunit a isoforms. Mouse genomic DNA (10 µg) was digested with BamHI (lane 1), BglII (lane 2), EcoRI (lane 3), EcoRV (lane 4), HincII (lane 5), HindIII (lane 6), PstI (lane 7), PvuII (lane 8), or XbaI (lane 9), and then electrophoresed on an agarose gel. After blotting, the filter was hybridized with radioactive probes of the indicated isoforms.

Induction of the a3 Isoform during Osteoclast Differentiation-- In osteoclasts, V-ATPase is distributed in the ruffled border membrane and acidifies the outside for bone resorption (8, 9). Thus, it became of interest to determine which isoform(s) was expressed in the plasma membrane of osteoclasts. Mouse bone marrow cells were cultured in the presence of 1,25(OH)2 D3 to develop osteoclasts in vitro (36). As shown in Fig. 4A, the a3 isoform was strongly expressed in the presence of 1,25(OH)2 D3. In contrast to a3, the a1 and a2 isoforms were constitutively synthesized regardless of the presence of 1,25(OH)2 D3; low but significant signals were observed for both isoforms. The time course of the appearance of the a3 isoform expression was consistent with the profile of osteoclast differentiation (Fig. 4B). These results indicated that only the a3 isoform was induced during osteoclast differentiation. Consistent with the increase in the a3 isoform in the Vo sector, the A and B subunits in the V1 sector were also induced on the addition of 1,25(OH)2 D3 (Fig. 4A), suggesting that the entire V-ATPase was induced during osteoclast differentiation.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Expression of subunit a isoforms during osteoclast differentiation. A, bone marrow cells were cultured for 7 days in the presence (+) or absence (-) of 1,25(OH)2 D3. Total cell proteins (7 µg) were separated by gel electrophoresis and then incubated with antibod- ies against a1, a2, or a3, or ones against subunit A (A). Expression of subunit B was essentially the same as that of subunit A (see Footnote 2). B, bone marrow cells were cultured for the indicated numbers of days in the presence of 1,25(OH)2 D3. Cells were subjected to tartrate-resistant acid phosphatase staining to determine the numbers of osteoclasts (OC). Cell nuclei were visualized by staining with methyl green. Scale bar indicates 200 µm. Total proteins (3 µg) were electrophoresed and blotted onto a filter. The immunoblot filter was analyzed by densitometry, and the amounts of the a3 isoform were estimated.

Presence of the a3 Isoform in the Osteoclast Plasma Membrane-- V-ATPases related to bone resorption should be localized in the plasma membrane to acidify the resorption lacuna. The intracellular distributions of the a1, a2, and a3 isoforms were determined by immunofluorescence microscopy using affinity-purified antibodies. The a1 isoform was found in the dot-like structures dispersed throughout the cytoplasm (Fig. 5, A and B), whereas the signal of the a3 isoform was detected on the plasma membrane and its vicinity (Fig. 5, C and D). No signals were detected with the anti-a2 antibodies, probably due to the low level of a2 expression in osteoclasts (Fig. 4A). Consistent with the induction of subunit A and B of V1 sector in the presence of 1,25(OH)2 D3, they were also detectable in the osteoclast plasma membrane (data not shown). These results indicated that the a3 isoform was predominantly located in the plasma membrane, and thus is a component of the V-ATPase responsible for bone resorption in osteoclasts.


View larger version (126K):
[in this window]
[in a new window]
 
Fig. 5.   Immunofluorescence analysis of the a1 and a3 isoforms in osteoclasts. After fixing with paraformaldehyde, cells were permeabilized and incubated with antibodies against a1 (A) or a3 (C), followed by fluorescein isothiocyanate-conjugated antibodies. Osteoclasts were identified as multi-nuclear cells exhibiting tartrate-resistant acid phosphatase staining. B and D are phase contrast images corresponding to A and C, respectively. The confocal images are of 8-µm sections. Scale bars indicate 50 µm.

Lee et al. recently reported that V-ATPase subunit E is co-localized with actin filaments in osteoclasts (13). The a3 isoform was also observed on the filamentous structures extending from the plasma membrane (Fig. 6, A and D). It was of interest to identify the filamentous structures. Actin filaments along the ruffled membrane were observed, as reported previously (10, 11). However, the filamentous structures stained with antibodies against the a3 isoform were different from actin filaments (Fig. 6, A-C). In contrast to actin filaments, microtubules were co-localized significantly with the filamentous structures (Fig. 6, D-F). These results indicated that the a3 isoform was associated with microtubules in osteoclasts.


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 6.   Co-localization of the a3 isoform with microtubules. Cells were fixed and permeabilized, followed by staining with either rhodamine-phalloidin (B) or anti-tubulin antibodies, YOL1/34 (E), together with antibodies against a3 (A and D). C and F represent merged images. The confocal images are of 1-µm sections. Scale bars indicate 20 µm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have identified three cDNA clones coding for the a1, a2, and a3 isoforms of mouse V-ATPase subunit a. They were expressed differently in the mouse tissues examined. The a1 isoform was mainly expressed in brain and exhibited high identity with subunit a from clathrin-coated vesicles of rat and bovine brain (30, 40). The a2 isoform exhibited 91% identity to the subunit a purified from bovine lung (34), although no a2 expression was detectable in mouse lung on Northern blotting. High levels of a3 expression were observed in brain and liver. It is tempting to assume that the different expression patterns of the isoforms are responsible for the diverse functions of V-ATPases in these tissues. The a1 and a2 isoforms contained one putative N-linked glycosylation site, whereas a3 had three sites. Consistent with these numbers of sites, the a3 isoform from mouse tissues migrated slower than the a1 and a2 ones on polyacrylamide gel electrophoresis.2

Yeast cells have two subunit a isoforms (Vph1p and Stv1p) (15, 16). Vph1p, the major form of subunit a, is localized in the vacuolar membrane, whereas Stv1p is located in the Golgi or endosomal membrane (16), suggesting that subunit a plays a functional role in targeting V-ATPases to their resident compartments. To determine which mouse isoform corresponds to Vph1p or Stv1p, expression plasmid carrying cDNA for the mouse a1, a2, or a3 isoform was introduced into the vph1 and stv1 mutant cells. However, no clones could complement the vph1 and stv1 mutations. These results are not surprising because the amino acid identities between Vph1p (or Stv1p) and mouse a isoforms are not high (36-40%).

Isoforms of V-ATPase subunit A, B, G, H, and a have been identified in vertebrates (25-27, 29-34). Mouse a subunits are the first example of all three isoforms being identified in the same higher eukaryote. Northern blot analysis revealed three transcripts for the a2 subunit and two for a3, possibly due to alternative splicing. These transcripts may cause further variation of subunit a. This variety of isoform combinations is enough to create the diversity of V-ATPases, which may establish different pH in acidic compartments. The different subunits may also contribute to the subcellular localization of the entire enzyme.

In osteoclasts, the B2 isoform is known to be specifically expressed and distributed in the plasma membrane (41, 42). Furthermore, the isoform was reported to be induced in osteoclasts generated from human blood monocytes (43). The a1, a2, and a3 isoforms were synthesized in osteoclasts, but only a3 was induced specifically and localized in the plasma membrane, suggesting that the V-ATPase subtype having the B2 and a3 isoforms is an inducible complex involved in bone resorption of osteoclasts. It is of interest to study the intracellular locations of the a3 isoform in heart and liver, where the a3 transcripts are predominantly expressed. The a2 isoform was expressed in thymus (25), implying that this isoform may be a component of the V-ATPase subtype related to immune responses.

Lee et al. (13) recently showed that subunit E of V-ATPase is co-localized and associated with actin filaments, suggesting that V-ATPase interacts with actin filaments during osteoclast activation. However, immunofluorescence analysis revealed that the filamentous structures of the a3 isoform staining were co-localized with microtubules but not with actin filaments. Treatment with cytochalasin D, an inhibitor of actin polymerization, showed no effect on the localization of the a3 subunit. However, no filamentous staining of the a3 isoform was observed by treatment with nocodazole, which causes microtubule depolymerization.2 These results suggest that the a3 isoform is associated with microtubules. Subunit A is co-localized with microtubules in avian osteoclast-like cells (44). It is difficult to assume that subunit a alone is transported from the endoplasmic reticulum without assembly as the Vo sector, because subunit a, if not assembled into V-ATPase, is susceptible of proteolytic degradation (1). Thus, V-ATPase (having the a3 isoform) in the transport vesicles may interact with microtubules and thereby be carried to the ruffled border membrane. In this regard, microtubules and microfilaments are known to be important for the trafficking of transport vesicles to their destinations (45).

    ACKNOWLEDGEMENT

We thank Dr. K. Kawashima (Teikyo University) for helping us to establish the in vitro culture of osteoclasts.

    FOOTNOTES

* This work was supported in part by a grant from the Ministry of Education, Science and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB022321 (a1), AB022323 (a2), and AB022322 (a3).

Dagger To whom correspondence should be addressed. Tel.: 81-6-6879-8480; Fax: 81-6-6875-5724; E-mail: m-futai@sanken.osaka-u.ac.jp.

2 T. Toyomura, T. Oka, and M. Futai, unpublished results.

    ABBREVIATIONS

The abbreviations used are: V-ATPase, vacuolar H+-ATPase; EST, expressed sequence tag; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; 1, 25(OH)2 D3, 1alpha ,25-dihydroxy cholecalciferol; bp, base pair(s); kb, kilobase pair(s); alpha -MEM, alpha -minimal essential medium.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Stevens, T. H., and Forgac, M. (1997) Annu. Rev. Cell Dev. Biol. 13, 779-808[CrossRef][Medline] [Order article via Infotrieve]
2. Anraku, Y. (1996) in Handbook of Biological Physics (Konings, W. N. , Kaback, H. R. , and Lolkema, J. S., eds), Vol. 2 , pp. 93-109, Elsevier Science Publishing Co., Inc., New York
3. Futai, M., Oka, T., Moriyama, Y., and Wada, Y. (1998) J. Biochem. (Tokyo) 124, 259-267[Abstract/Free Full Text]
4. Nelson, N., and Harvey, W. R. (1999) Physiol. Rev. 79, 361-385[Abstract/Free Full Text]
5. Brown, D., and Breton, S. (1996) J. Exp. Biol. 199, 2345-2358[Abstract]
6. Brown, D., Smith, P. J., and Breton, S. (1997) J. Exp. Biol. 200, 257-262[Abstract]
7. Tomochika, K., Shinoda, S., Kumon, H., Mori, M., Moriyama, Y., and Futai, M. (1997) FEBS Lett. 404, 61-64[CrossRef][Medline] [Order article via Infotrieve]
8. Blair, H. C., Teitelbaum, S. L., Ghiselli, R., and Gluck, S. (1989) Science 245, 855-857[Abstract/Free Full Text]
9. Nakamura, H., Moriyama, Y., Futai, M., and Ozawa, H. (1994) Arch. Histol. Cytol. 57, 535-539[Medline] [Order article via Infotrieve]
10. Lakkakorpi, P. T., and Väänänen, H. K. (1991) J. Bone Miner. Res. 6, 817-826[Medline] [Order article via Infotrieve]
11. Turksen, K., Kanehisa, J., Opas, M., Heersche, J. N., and Aubin, J. E. (1988) J. Bone Miner. Res. 3, 389-400[Medline] [Order article via Infotrieve]
12. Nakamura, I., Takahashi, N., Udagawa, N., Moriyama, Y., Kurokawa, T., Jimi, E., Sasaki, T., and Suda, T. (1997) FEBS Lett. 401, 207-212[CrossRef][Medline] [Order article via Infotrieve]
13. Lee, B. S., Gluck, S. L., and Holliday, L. S. (1999) J. Biol. Chem. 274, 29164-29171[Abstract/Free Full Text]
14. Futai, M., and Omote, H. (1996) J. Bioenerg. Biomembr. 28, 409-414[CrossRef][Medline] [Order article via Infotrieve]
15. Manolson, M. F., Proteau, D., and Jones, E. W. (1992) J. Exp. Biol. 172, 105-112[Abstract/Free Full Text]
16. Manolson, M. F., Wu, B., Proteau, D., Taillon, B. E., Roberts, B. T., Hoyt, M. A., and Jones, E. W. (1994) J. Biol. Chem. 269, 14064-14074[Abstract/Free Full Text]
17. Oka, T., Yamamoto, R., and Futai, M. (1997) J. Biol. Chem. 272, 24387-24392[Abstract/Free Full Text]
18. Oka, T., Yamamoto, R., and Futai, M. (1998) J. Biol. Chem. 273, 22570-22576[Abstract/Free Full Text]
19. Umemoto, N., Yoshihisa, T., Hirata, R., and Anraku, Y. (1990) J. Biol. Chem. 265, 18447-18453[Abstract/Free Full Text]
20. Umemoto, N., Ohya, Y., and Anraku, Y. (1991) J. Biol. Chem. 266, 24526-24532[Abstract/Free Full Text]
21. Hirata, R., Graham, L. A., Takatsuki, A., Stevens, T. H., and Anraku, Y. (1997) J. Biol. Chem. 272, 4795-4803[Abstract/Free Full Text]
22. Hasebe, M., Hanada, H., Moriyama, Y., Maeda, M., and Futai, M. (1992) Biochem. Biophys. Res. Commun. 183, 856-863[CrossRef][Medline] [Order article via Infotrieve]
23. Hernando, N., Bartkiewicz, M., Collin-Osdoby, P., Osdoby, P., and Baron, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6087-6091[Abstract/Free Full Text]
24. Hasenfratz, M. P., Tsou, C. L., and Wilkins, T. A. (1995) Plant Physiol. 108, 1395-1404[Abstract]
25. Lee, C., Ghoshal, K., and Beaman, K. D. (1990) Mol. Immunol. 27, 1137-1144[CrossRef][Medline] [Order article via Infotrieve]
26. Puopolo, K., Kumamoto, C., Adachi, I., Magner, R., and Forgac, M. (1992) J. Biol. Chem. 267, 3696-3706[Abstract/Free Full Text]
27. Nelson, N. (1992) J. Bioenerg. Biomembr. 24, 407-414[CrossRef][Medline] [Order article via Infotrieve]
28. Hemken, P., Guo, X. L., Wang, Z. Q., Zhang, K., and Gluck, S. (1992) J. Biol. Chem. 267, 9948-9957[Abstract/Free Full Text]
29. van Hille, B., Richener, H., Evans, D. B., Green, J. R., and Bilbe, G. (1993) J. Biol. Chem. 268, 7075-7080[Abstract/Free Full Text]
30. Peng, S.-B., Crider, B. P., Xie, X.-S., and Stone, D. K. (1994) J. Biol. Chem. 269, 17262-17266[Abstract/Free Full Text]
31. Li, Y. P., Chen, W., and Stashenko, P. (1996) Biochem. Biophys. Res. Commun. 218, 813-821[CrossRef][Medline] [Order article via Infotrieve]
32. Crider, B. P., Andersen, P., White, A. E., Zhou, Z., Li, X., Mattsson, J. P., Lundberg, L., Keeling, D. J., Xie, X.-S., Stone, D. K., and Peng, S.-B. (1997) J. Biol. Chem. 272, 10721-10728[Abstract/Free Full Text]
33. Zhou, Z., Peng, S.-B., Crider, B. P., Slaughter, C., Xie, X.-S., and Stone, D. K. (1998) J. Biol. Chem. 273, 5878-5884[Abstract/Free Full Text]
34. Peng, S.-B., Li, X., Crider, B. P., Zhou, Z., Andersen, P., Tsai, S. J., Xie, X.-S., and Stone, D. K. (1999) J. Biol. Chem. 274, 2549-2555[Abstract/Free Full Text]
35. Karet, F. E., Finberg, K. E., Nelson, R. D., Nayir, A., Mocan, H., Sanjad, S. A., Rodriguez-Soriano, J., Santos, F., Cremers, C. W., Di Pietro, A., Hoffbrand, B. I., Winiarski, J., Bakkaloglu, A., Ozen, S., Dusunsel, R., Goodyer, P., Hulton, S. A., Wu, D. K., Skvorak, A. B., Morton, C. C., Cunningham, M. J., Jha, V., and Lifton, R. P. (1999) Nat. Genet. 21, 84-90[CrossRef][Medline] [Order article via Infotrieve]
36. Takahashi, N., Akatsu, T., Sasaki, T., Nicholson, G. C., Moseley, J. M., Martin, T. J., and Suda, T. (1988) Endocrinology 123, 1504-1510[Abstract]
37. Yamashita, T., Asano, K., Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Martin, T. J., and Suda, T. (1990) J. Cell. Physiol. 145, 587-595[CrossRef][Medline] [Order article via Infotrieve]
38. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132[CrossRef][Medline] [Order article via Infotrieve]
39. Leng, X.-H., Nishi, T., and Forgac, M. (1999) J. Biol. Chem. 274, 14655-14661[Abstract/Free Full Text]
40. Perin, M. S., Fried, V. A., Stone, D. K., Xie, X.-S., and Südhof, T. C. (1991) J. Biol. Chem. 266, 3877-3881[Abstract/Free Full Text]
41. Lee, B. S., Holliday, L. S., Ojikutu, B., Krits, I., and Gluck, S. L. (1996) Am. J. Physiol. 270, 382-388
42. Mattsson, J. P., Skyman, C., Palokangas, H., Väänänen, K. H., and Keeling, D. J. (1997) J. Bone Miner. Res. 12, 753-760[CrossRef][Medline] [Order article via Infotrieve]
43. Higuchi, Y., Ito, M., Tajima, M., Higuchi, S., Miyamoto, N., Nishio, M., Kawano, M., Kusagawa, S., Tsurudome, M., Sudo, A., Katou, K., Uchida, A., and Ito, Y. (1999) Bone 25, 17-24[Medline] [Order article via Infotrieve]
44. Abu-Amer, Y., Ross, F. P., Schlesinger, P., Tondravi, M. M., and Teitelbaum, S. L. (1997) J. Cell Biol. 137, 247-258[Abstract/Free Full Text]
45. Hirokawa, N. (1998) Science 279, 519-526[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Feng, T. Cheng, N. J. Pavlos, K. H. M. Yip, A. Carrello, R. Seeber, K. Eidne, M. H. Zheng, and J. Xu
Cytoplasmic Terminus of Vacuolar Type Proton Pump Accessory Subunit Ac45 Is Required for Proper Interaction with V0 Domain Subunits and Efficient Osteoclastic Bone Resorption
J. Biol. Chem., May 9, 2008; 283(19): 13194 - 13204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Da Silva, W. W. C. Shum, J. El-Annan, T. G. Paunescu, M. McKee, P. J. S. Smith, D. Brown, and S. Breton
Relocalization of the V-ATPase B2 subunit to the apical membrane of epididymal clear cells of mice deficient in the B1 subunit
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C199 - C210.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. K. Johansson, T. J. de Vries, T. Schoenmaker, M. Ehinger, A. C. M. Brun, A. Fasth, S. Karlsson, V. Everts, and J. Richter
Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice
Blood, June 15, 2007; 109(12): 5178 - 5185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Breton and D. Brown
New insights into the regulation of V-ATPase-dependent proton secretion
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F1 - F10.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G.-H. Sun-Wada, T. Toyomura, Y. Murata, A. Yamamoto, M. Futai, and Y. Wada
The a3 isoform of V-ATPase regulates insulin secretion from pancreatic {beta}-cells
J. Cell Sci., November 1, 2006; 119(21): 4531 - 4540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Edwards, C. Cohen, W. Xu, and P. H. Schlesinger
c-Src Control of Chloride Channel Support for Osteoclast HCl Transport and Bone Resorption
J. Biol. Chem., September 22, 2006; 281(38): 28011 - 28022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Poea-Guyon, M. Amar, P. Fossier, and N. Morel
Alternative Splicing Controls Neuronal Expression of v-ATPase Subunit a1 and Sorting to Nerve Terminals
J. Biol. Chem., June 23, 2006; 281(25): 17164 - 17172.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
J. Dettmer, A. Hong-Hermesdorf, Y.-D. Stierhof, and K. Schumacher
Vacuolar H+-ATPase Activity Is Required for Endocytic and Secretory Trafficking in Arabidopsis
PLANT CELL, March 1, 2006; 18(3): 715 - 730.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
K. W. Beyenbach and H. Wieczorek
The V-type H+ ATPase: molecular structure and function, physiological roles and regulation
J. Exp. Biol., February 15, 2006; 209(4): 577 - 589.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. Wassmer, R. Kissmehl, J. Cohen, and H. Plattner
Seventeen a-Subunit Isoforms of Paramecium V-ATPase Provide High Specialization in Localization and Function
Mol. Biol. Cell, February 1, 2006; 17(2): 917 - 930.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Pietrement, G-H. Sun-Wada, N. D. Silva, M. McKee, V. Marshansky, D. Brown, M. Futai, and S. Breton
Distinct Expression Patterns of Different Subunit Isoforms of the V-ATPase in the Rat Epididymis
Biol Reprod, January 1, 2006; 74(1): 185 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. Smith, F. Jouret, S. Bord, K. J. Borthwick, R. S. Al-Lamki, C. A. Wagner, D. C. Ireland, V. Cormier-Daire, A. Frattini, A. Villa, et al.
Vacuolar H+-ATPase d2 Subunit: Molecular Characterization, Developmental Regulation, and Localization to Specialized Proton Pumps in Kidney and Bone
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1245 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Beaulieu, N. Da Silva, N. Pastor-Soler, C. R. Brown, P. J. S. Smith, D. Brown, and S. Breton
Modulation of the Actin Cytoskeleton via Gelsolin Regulates Vacuolar H+-ATPase Recycling
J. Biol. Chem., March 4, 2005; 280(9): 8452 - 8463.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. A. Wagner, K. E. Finberg, S. Breton, V. Marshansky, D. Brown, and J. P. Geibel
Renal Vacuolar H+-ATPase
Physiol Rev, October 1, 2004; 84(4): 1263 - 1314.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. A. Derks and K. D. Beaman
Regeneration and Tolerance Factor Prevents Bystander T-Cell Death Associated with Human Immunodeficiency Virus Infection
Clin. Vaccine Immunol., September 1, 2004; 11(5): 835 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lu, Y. Y. Sautin, L. S. Holliday, and S. L. Gluck
The Glycolytic Enzyme Aldolase Mediates Assembly, Expression, and Activity of Vacuolar H+-ATPase
J. Biol. Chem., March 5, 2004; 279(10): 8732 - 8739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-H. Chen, M. R. Bubb, E. G. Yarmola, J. Zuo, J. Jiang, B. S. Lee, M. Lu, S. L. Gluck, I. R. Hurst, and L. S. Holliday
Vacuolar H+-ATPase Binding to Microfilaments: REGULATION IN RESPONSE TO PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY AND DETAILED CHARACTERIZATION OF THE ACTIN-BINDING SITE IN SUBUNIT B
J. Biol. Chem., February 27, 2004; 279(9): 7988 - 7998.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Manolson, H. Yu, W. Chen, Y. Yao, K. Li, R. L. Lees, and J. N. M. Heersche
The a3 Isoform of the 100-kDa V-ATPase Subunit Is Highly but Differentially Expressed in Large ("=" BORDER="0">10 Nuclei) and Small (5 Nuclei) Osteoclasts</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December 5, 2003;
	278(49):
	49271 - 49278.
<BR>
<A HREF=[Abstract] [Full Text] [PDF]